Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,622 | 487 | 31.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,045 | 5 | 23.8% |
| Honoraria | $7,580 | 5 | 16.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $5,213 | 4 | 11.2% |
| Consulting Fee | $4,550 | 2 | 9.8% |
| Travel and Lodging | $3,294 | 8 | 7.1% |
| Education | $151.46 | 5 | 0.3% |
| Gift | $19.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $14,227 | 40 | $0 (2019) |
| Dompe US, Inc. | $14,218 | 34 | $0 (2024) |
| TISSUETECH, INC. | $5,678 | 21 | $0 (2021) |
| BIOTISSUE HOLDINGS INC. | $1,886 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,167 | 47 | $0 (2024) |
| Alcon Vision LLC | $1,036 | 42 | $0 (2024) |
| ABBVIE INC. | $838.98 | 35 | $0 (2024) |
| Allergan, Inc. | $833.15 | 44 | $0 (2022) |
| Sight Sciences, Inc. | $674.76 | 9 | $0 (2024) |
| Oyster Point Pharma, Inc. | $527.64 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,964 | 92 | BIOTISSUE HOLDINGS INC. ($1,587) |
| 2023 | $6,865 | 71 | Dompe US, Inc. ($5,080) |
| 2022 | $2,419 | 64 | Dompe US, Inc. ($747.46) |
| 2021 | $6,218 | 68 | Dompe US, Inc. ($4,820) |
| 2020 | $556.97 | 26 | Dompe US, Inc. ($155.49) |
| 2019 | $9,484 | 59 | TissueTech, Inc. ($4,948) |
| 2018 | $6,867 | 75 | Shire North American Group Inc ($5,232) |
| 2017 | $10,099 | 62 | Shire North American Group Inc ($8,960) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch & Lomb Americas Inc. | ENVISTA ENVY (Device) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Ophthalmology | ||||||
| 12/19/2024 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $21.62 | General |
| 12/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Dry eyes | ||||||
| 11/27/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $54.78 | General |
| 11/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: EYE CARE | ||||||
| 11/21/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: OPTOMETRY | ||||||
| 11/13/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: EYE CARE | ||||||
| 11/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Ophthalmology | ||||||
| 11/01/2024 | Glaukos Corporation | Photrexa (Drug) | Food and Beverage | Cash or cash equivalent | $29.65 | General |
| Category: Corneal Health | ||||||
| 10/31/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Dry eyes | ||||||
| 10/29/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: OPTOMETRY | ||||||
| 10/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: EYE CARE | ||||||
| 10/09/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: EYE CARE | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Ophthalmology | ||||||
| 09/27/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $0.44 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,925 | 2,263 | $1.1M | $232,287 |
| 2022 | 21 | 2,294 | 2,786 | $1.2M | $272,505 |
| 2021 | 20 | 2,232 | 2,635 | $1.1M | $264,022 |
| 2020 | 19 | 1,718 | 1,961 | $774,285 | $184,317 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 114 | 186 | $563,858 | $83,056 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 453 | $79,325 | $42,594 | 53.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 57 | 77 | $154,000 | $21,430 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 234 | $29,250 | $16,221 | 55.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 135 | 215 | $26,875 | $14,833 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $19,400 | $11,629 | 59.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 18 | $72,000 | $11,047 | 15.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 257 | 265 | $53,000 | $9,119 | 17.2% |
| 92134 | Imaging of retina | Office | 2023 | 197 | 231 | $57,750 | $7,197 | 12.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 84 | 88 | $13,063 | $4,081 | 31.2% |
| 92025 | Ct scan of cornea | Office | 2023 | 116 | 120 | $9,600 | $3,196 | 33.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 109 | 117 | $29,008 | $2,993 | 10.3% |
| 92250 | Photography of the retina | Office | 2023 | 56 | 58 | $14,500 | $1,486 | 10.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 12 | 12 | $2,100 | $1,119 | 53.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,100 | $915.03 | 43.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 30 | 30 | $3,000 | $611.00 | 20.4% |
| 92285 | Photography of content of eyes | Office | 2023 | 27 | 29 | $1,475 | $590.44 | 40.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 19 | 19 | $950.00 | $170.79 | 18.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 101 | 163 | $489,000 | $75,307 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 444 | 532 | $93,125 | $51,351 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 285 | 464 | $58,000 | $31,120 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 157 | 157 | $31,400 | $19,723 | 62.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 43 | 68 | $136,000 | $19,168 | 14.1% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 17 | 24 | $96,000 | $15,392 | 16.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 122 | 174 | $21,750 | $11,912 | 54.8% |
About Dr. Mary Davidian, MD
Dr. Mary Davidian, MD is a Ophthalmology healthcare provider based in New Windsor, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780683052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Davidian, MD has received a total of $46,474 in payments from pharmaceutical and medical device companies, with $3,964 received in 2024. These payments were reported across 517 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($14,622).
As a Medicare-enrolled provider, Davidian has provided services to 8,169 Medicare beneficiaries, totaling 9,645 services with total Medicare billing of $953,132. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location New Windsor, NY
- Active Since 07/19/2005
- Last Updated 06/17/2010
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1780683052
Products in Payments
- XIIDRA (Drug) $14,641
- OXERVATE (Drug) $10,814
- Prokera (Device) $5,637
- Oxervate (Drug) $3,405
- ACTHAR (Biological) $736.57
- Cequa (Drug) $635.59
- TYRVAYA (Drug) $527.64
- LUMIGAN (Drug) $506.51
- LENSAR LASER SYSTEM (Device) $428.35
- DURYSTA (Drug) $416.66
- TearLab Osmolarity System (Device) $370.37
- OMNI (Device) $366.70
- PROKERA (Device) $340.23
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $308.56
- rocklatan (Drug) $287.84
- INVELTYS (Drug) $279.62
- Rhopressa (Drug) $193.70
- Bromsite (Drug) $186.57
- DEXYCU (Drug) $181.35
- RESTASIS (Drug) $181.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.